Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

Prostate cancer, a prevalent male cancer, can be detected early through a simple PSA blood test, significantly reducing ...

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

Dr. Wallen: When the prostate cancer is only in the prostate and hasn't spread elsewhere, the standard of care treatments are ...

About one in eight men will be diagnosed with prostate cancer during their lifetime, according to the American Cancer Society ...

Rock City Hotel has once again demonstrated its commitment to community well-being through a free prostate and breast cancer screening exercise organised for members of the Project Management ...

Health experts warn that one in eight men will be diagnosed with cancer in their lifetime, emphasizing the importance of recognizing early warning signs. Symptoms such as unexplained weight loss, ...

Shares in diagnostic play Nexsen have traded as much as 47% higher after debuting on the ASX today, following an $8 million ...

Lantheus Holdings Inc. (NASDAQ:LNTH) is one of the best value stocks to invest in now. On October 8, Goldman Sachs downgraded ...

Targeted prostate checks would save lives at a cost of just £18 per head, research has found. Experts said offering tests to men at most risk would prevent thousands of deaths, amounting to more than ...

Medshield Medical Scheme launched its benefit options and contributions for 2026, building on its Partner for Life offering with a strong member-centric theme of Predict and Prevent.